Orion Corporation has received Irish and Hungarian marketing authorisation for Bufomix Easyhaler®, an inhaled budesonide-formoterol combination product indicated for asthma and chronic obstructive ...
Nycomed / Nycomed and Orion Corporation to collaborate on Easyhaler® for asthma and COPD . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this ...
Press release 2 September 2016 at 1.00 p.m. EEST Orion Corporation announced today that it has entered into a collaboration agreement with Menarini Group, for the co-marketing of budesonide-formoterol ...
(ShareCast News) - Hikma Pharmaceuticals has signed an exclusive licensing and distribution agreement with Finland's Orion for its new Easyhaler combination product for the treatment of asthma and ...
Finnish drugmaker Orion on Friday reported a bigger-than-expected rise in quarterly profit helped by strong sales of prostate cancer treatment Nubeqa and its Easyhaler products. July 15 (Reuters) - ...
ORION CORPORATION STOCK EXCHANGE RELEASE 14 APRIL 2014 at 9:30 PM EEST Orion receives first marketing authorisations for Bufomix Easyhaler® product Orion Corporation has received Irish and Hungarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results